Individualized Treatment of Acute Achilles Tendon Rupture
Individualized Treatment for Acute Achilles Tendon Rupture Based on Barfod's Ultrasonographic Length Measure - a Randomized Controlled Trial
1 other identifier
interventional
300
1 country
4
Brief Summary
To asses the functional outcome after individualized treatment of acute achilles tendon rupture. The treatment is individualizes on the basis of ultrasonographic status of tendon overlap and Barfod's Ultrasonographic length measure. Patients are allocated for operative treatment if there the tendon overlap is less than 25 % or the tendon is elongated with 7% or more compared to the healthy, contralateral achilles tendon. The study includes two control groups of non-operative and operative treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2018
CompletedFirst Posted
Study publicly available on registry
May 16, 2018
CompletedStudy Start
First participant enrolled
October 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 24, 2024
CompletedJanuary 3, 2025
January 1, 2025
6 years
March 20, 2018
January 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Heel-rise work test
An endurance test where the patient stands on one leg and lifts the heel up and down until exhaustion. The number and the height of the heel rises are counted and measured and plotted into a diagram on an X-axis and Y-axis respectively. The results are then compared to the weight of the patient and the total work is estimated as area under the curve. The heel lift distance between the heel and the floor is measured in millimeters. The procedure is performed on the uninjured leg first and subsequently on the injured leg. The patient is barefoot for the heel-rise work test and stands on a flat surface with a 10 degree inclination. For these functional tests a measurement system MuscleLab (Ergotest Technology, Oslo, Norway) will be used at all the centers.
Evaluation method after 12 months of started treatment
Secondary Outcomes (5)
Barfod's ultrasonographic length measure
Evaluation method after 6 and 12 months of started treatment
Indirectly, clinical Achilles tendon length estimate
Evaluation method after 6 and 12 months of started treatment
Complications
Evaluation method after 12 months of started treatment
Achilles tendon Total Rupture Score (ATRS)
Evaluation method after 6 and 12 months of started treatment
Heel-rise Work test
Evaluation method after 6 months of started treatment
Study Arms (3)
Individualized treatment
EXPERIMENTALThe ruptured achilles tendon is examined by ultrasonography. If the overlap of the tendon ends is less than 25 % or the tendon is elongated 7 % or more the patient receives conventional open operative treatment. The tendon is sutured with double fiberwire size 2 a.m. Kessler under prophylactic Dicloxacillin 2 g and in local anaesthesia or alternatively popliteal or spinal block. The injured leg is placed in a circulated below-the-knee cast after surgery. The ankle is held at maximal, unforced plantar flexion. Weight bearing is not allowed and the patient should walk with the aid of crutches. After 3 weeks from initiated treatment in the Emergency Department the cast is removed in the Outpatients Department and the injured leg is transferred to a functional brace (Walker boot) with 3 heel wedges promoting 20 degrees plantar flexion over the ankle. The patient will follow standard functional rehabilitation and the follow-up evaluations.
Control group 1
ACTIVE COMPARATORFor the patients allocated to non-operative treatment the injured leg is placed in a circulated below-the-knee cast from the time of the first appointment in the Outpatients Department. The ankle is held at maximal, unforced plantar flexion. Weight bearing is not allowed and the patient should walk with the aid of crutches. After 3 weeks from initiated treatment in the Emergency Department the cast is removed in the Outpatients Department and the injured leg is transferred to a functional brace (Walker boot) with 3 heel wedges promoting 20 degrees plantar flexion over the ankle. The patient will follow standard functional rehabilitation and the follow-up evaluations.
Control group 2
ACTIVE COMPARATORThe tendon is sutured with double fiberwire size 2 a.m. Kessler under prophylactic Dicloxacillin 2 g and in local anaesthesia or alternatively popliteal or spinal block. The injured leg is placed in a circulated below-the-knee cast from the time of the first appointment in the Outpatients Department. The ankle is held at maximal, unforced plantar flexion. Weight bearing is not allowed and the patient should walk with the aid of crutches. After 3 weeks from initiated treatment in the Emergency Department the cast is removed in the Outpatients Department and the injured leg is transferred to a functional brace (Walker boot) with 3 heel wedges promoting 20 degrees plantar flexion over the ankle. The patient will follow standard functional rehabilitation and the follow-up evaluations.
Interventions
The most proximal border of the calcaneus and the most distal point of the musculotendinous junction of the Achilles tendon and the medial gastrocnemius muscle is identified and marked on the skin. These two points on the un-injured leg defines the original length of the total Achilles tendon and consist of the free tendon and the fascia \[1\]. The difference in length between the injure and the un-injured leg determines elongation for the ruptured Achilles tendon. The relative elongation of the ruptured tendon together with overlap of the tendon ends on the cross-sectional area determines the treatment for the patients receiving individualized treatment: 1) patients with 0-6% elongation of the tendon and a minimum of 25% tendon are treated non-operatively 2) patients with 7% elongation or more or less than 25% tendon overlap are treated operatively. The cut-off at 7% elongation is determined for 75% sensitivity and 65% specificity of elongation.
Circulated cast below the knee in maximal, unforced plantar flexion over the ankel.
Open surgery with suture of the ruptured achilles tendon prior to circulated cast below the knee in maximal, unforced plantar flexion over the ankel.
Eligibility Criteria
You may qualify if:
- Appointment in the Outpatients Department within 4 days of injury.
- Total Achilles tendon rupture.
- Initial treatment with split cast with the ankle in maximal plantar flexion must be started within 24 hours of injury.
- The patient must be expected to be able to attend rehabilitation and post-examinations.
- The patient must be able to speak and understand Danish.
- The patient must be able to give informed consent.
You may not qualify if:
- Rupture of the Achilles tendon either at the insertion on the calcaneus or at musculotendinous junction of the triceps surae.
- Previous rupture of the Achilles tendon in any of the two legs.
- Treated with Fluoroquinolones or corticosteroids within the last 6 months.
- In medical treatment of diabetes.
- Suffers from rheumatic disease.
- Other conditions prior to the injury resulting in reduced function of any of the two legs.
- Contra-indication for surgery: severe arthrosclerosis with no palpable pulse in the foot, broken skin in the Achilles region of the injured leg.
- Inability to lie in prone position on the operating table.
- Terminal illness or severe medical illness: ASA (American Society of Anesthesiologists) score higher than or equal to 3.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Copenhagen University Hospital, Hvidovre
Hvidovre, DK-2650, Denmark
Hospital Lillte Belt, Kolding
Kolding, DK-6000, Denmark
Zealand University Hospital, Køge
Køge, DK-4600, Denmark
Jutland Central Regional Hospital
Viborg, DK-8800, Denmark
Related Publications (2)
Barfod KW, Riecke AF, Boesen A, Hansen P, Maier JF, Dossing S, Troelsen A. Validation of a novel ultrasound measurement of achilles tendon length. Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3398-406. doi: 10.1007/s00167-014-3175-2. Epub 2014 Jul 20.
PMID: 25038882BACKGROUNDHansen MS, Vestermark MT, Holmich P, Kristensen MT, Barfod KW. Individualized treatment for acute Achilles tendon rupture based on the Copenhagen Achilles Rupture Treatment Algorithm (CARTA): a study protocol for a multicenter randomized controlled trial. Trials. 2020 May 12;21(1):399. doi: 10.1186/s13063-020-04332-z.
PMID: 32398120DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Marianne T Vestermark, MD PhD
Central Jutland Regional Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The posterior site of the achilles tendon region is covered by dark tape during the functional assesments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Orthopaedic Resaerch, MD PhD
Study Record Dates
First Submitted
March 20, 2018
First Posted
May 16, 2018
Study Start
October 2, 2018
Primary Completion
September 24, 2024
Study Completion
September 24, 2024
Last Updated
January 3, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
There is no plan of sharing data with researchers not already included in this study.